Tiffany Yating Hsu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rheumatic Diseases | 8 | 2023 | 649 | 0.940 |
Why?
|
Spliceosomes | 2 | 2021 | 117 | 0.660 |
Why?
|
Genes, myc | 2 | 2015 | 390 | 0.550 |
Why?
|
Rheumatology | 4 | 2022 | 615 | 0.510 |
Why?
|
Antirheumatic Agents | 3 | 2022 | 1366 | 0.290 |
Why?
|
Arthritis, Rheumatoid | 4 | 2022 | 3754 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2021 | 987 | 0.260 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2022 | 2157 | 0.170 |
Why?
|
Myositis | 1 | 2022 | 270 | 0.160 |
Why?
|
Autoimmune Diseases | 2 | 2022 | 2243 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 165 | 0.160 |
Why?
|
Lung Injury | 1 | 2022 | 422 | 0.150 |
Why?
|
Introns | 2 | 2021 | 968 | 0.140 |
Why?
|
Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 20 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2015 | 2820 | 0.130 |
Why?
|
RNA Splicing | 2 | 2021 | 896 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2020 | 858 | 0.120 |
Why?
|
Respiration, Artificial | 3 | 2021 | 2630 | 0.120 |
Why?
|
Immunity | 1 | 2021 | 996 | 0.120 |
Why?
|
RNA Precursors | 1 | 2015 | 196 | 0.120 |
Why?
|
Psoriasis | 1 | 2021 | 945 | 0.110 |
Why?
|
Breast Neoplasms | 3 | 2015 | 20981 | 0.110 |
Why?
|
Ribonucleoproteins | 1 | 2015 | 356 | 0.110 |
Why?
|
Glutarates | 1 | 2013 | 243 | 0.100 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2011 | 85 | 0.100 |
Why?
|
Mice, Nude | 2 | 2015 | 3604 | 0.100 |
Why?
|
Premature Birth | 1 | 2023 | 1781 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2015 | 8529 | 0.090 |
Why?
|
Cell Dedifferentiation | 1 | 2011 | 122 | 0.090 |
Why?
|
Isoxazoles | 1 | 2011 | 233 | 0.080 |
Why?
|
HeLa Cells | 1 | 2015 | 3073 | 0.080 |
Why?
|
Hospitalization | 4 | 2021 | 10712 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2021 | 3048 | 0.080 |
Why?
|
Neoplasm Metastasis | 2 | 2015 | 4908 | 0.070 |
Why?
|
Cell Line, Tumor | 4 | 2021 | 16947 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3591 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2423 | 0.070 |
Why?
|
Thiophenes | 1 | 2011 | 569 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2015 | 2443 | 0.070 |
Why?
|
Cell Survival | 1 | 2015 | 5776 | 0.060 |
Why?
|
Registries | 4 | 2022 | 8236 | 0.060 |
Why?
|
Neurogenesis | 1 | 2011 | 861 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4583 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2014 | 2974 | 0.060 |
Why?
|
Gene Amplification | 2 | 2021 | 1084 | 0.050 |
Why?
|
Astrocytes | 1 | 2011 | 1341 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3094 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3216 | 0.050 |
Why?
|
Female | 15 | 2023 | 392458 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2014 | 7574 | 0.050 |
Why?
|
Prednisolone | 1 | 2022 | 324 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5781 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2015 | 12743 | 0.040 |
Why?
|
Humans | 19 | 2023 | 761098 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 290 | 0.040 |
Why?
|
Middle Aged | 9 | 2022 | 220835 | 0.040 |
Why?
|
Mice | 5 | 2021 | 81324 | 0.040 |
Why?
|
Male | 11 | 2022 | 360675 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8836 | 0.040 |
Why?
|
Prednisone | 1 | 2022 | 1565 | 0.040 |
Why?
|
Cytoplasm | 1 | 2021 | 1498 | 0.030 |
Why?
|
Antibody Formation | 1 | 2021 | 1391 | 0.030 |
Why?
|
Signal Transduction | 2 | 2021 | 23415 | 0.030 |
Why?
|
Glioma | 1 | 2011 | 3452 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1837 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2021 | 724 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 3409 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2022 | 15845 | 0.030 |
Why?
|
Alcohol Oxidoreductases | 1 | 2013 | 163 | 0.030 |
Why?
|
Animals | 5 | 2021 | 168083 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9478 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6305 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3328 | 0.020 |
Why?
|
Sumoylation | 1 | 2011 | 83 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8663 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3368 | 0.020 |
Why?
|
Glutamine | 1 | 2013 | 574 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3149 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2813 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1602 | 0.020 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2011 | 506 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9648 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 41486 | 0.020 |
Why?
|
Aged | 4 | 2021 | 169266 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2011 | 2010 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2013 | 974 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2013 | 937 | 0.020 |
Why?
|
Adult | 4 | 2022 | 221083 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10514 | 0.020 |
Why?
|
Metabolome | 1 | 2013 | 989 | 0.020 |
Why?
|
Mitosis | 1 | 2011 | 1186 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2011 | 773 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2013 | 2208 | 0.020 |
Why?
|
United States | 2 | 2022 | 72337 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8303 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2926 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2381 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3443 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2816 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 80673 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2011 | 1348 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 26187 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4510 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29872 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10083 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 2802 | 0.010 |
Why?
|
Mitochondria | 1 | 2013 | 3620 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26068 | 0.010 |
Why?
|
DNA Methylation | 1 | 2013 | 4386 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54419 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 3790 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9416 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 18926 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10421 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59199 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74219 | 0.010 |
Why?
|
Prognosis | 1 | 2013 | 29672 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 88271 | 0.010 |
Why?
|
Neurons | 1 | 2011 | 9435 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 64670 | 0.000 |
Why?
|